Heska Announces Q310 Results

Mon, 11/15/2010 - 5:34am

LOVELAND, Colo., Nov. 15, 2010 /PRNewswire-FirstCall/ -- Heska Corporation (Nasdaq: HSKA, "Heska" or the "Company") today reported financial results for its third quarter ended September 30, 2010.



"These results exceed our revenue expectations and most recent revenue guidance.  We had a particularly strong quarter in our Other Vaccines, Pharmaceuticals and Products segment where the USDA validated an improved process for our line of cattle vaccines, allowing us to ship a significant quantity of product in a category which had previously been on hold due to regulatory discussions," said Robert Grieve, Heska's Chairman and CEO.  "As we have reported over the course of 2010, we faced a difficult year-over-year comparison in our Core Companion Animal Health segment as we are no longer selling the old line of handheld blood analysis instruments and affiliated consumables.  This product area accounted for over $2.7 million in revenue in the third quarter of 2009, with no such revenue in the third quarter of 2010."

Investor Conference CallManagement will conduct a conference call on Monday, November 15, 2010 at 9:00 a.m. MST (11:00 a.m. EST) to discuss the third quarter 2010 financial results.  To participate, dial (800) 762-8779 (domestic) or (480) 629-9771 (international); the conference call access number is 4371990.  The conference call will also be broadcast live over the Internet at  To listen, simply log on to the web at this address at least ten minutes prior to the start of the call to register, download and install any necessary audio software.  Telephone replays




Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.